key: cord-0894717-gsvtl3ef
authors: Budhram, Samantha; Vannevel, Valerie; Botha, Tanita; Chauke, Lawrence; Bhoora, Shastra; Balie, Gaynor M.; Odell, Natalie; Lombaard, Hennie; Wise, Amy; Georgiou, Chrysanthi; Ngxola, Nondumiso; Wynne, Emma; Mbewu, Unati; Mabenge, Mfundo; Phinzi, Sibusiso; Gubu‐Ntaba, Nontsikelelo; Goldman, Gareth; Tunkyi, Kay; Prithipal, Sudhir; Naidoo, Keshree; Venkatachalam, Santhi; Moodley, Terence; Mould, Sean; Hlabisa, Mzuvele; Govender, Logie; Maistry, Charlene; Habineza, John P.; Israel, Priya; Foolchand, Serantha; Tsibiyane, Nomandla V.; Panday, Mala; Soma‐Pillay, Priya; Adam, Sumaiya; Molokoane, Felicia; Mojela, Matthew S.; van Rensburg, Elizabeth J.; Mashamba, Tshililo; Matjila, Mushi; Fawcus, Sue; Osman, Ayesha; Venter, Mareli; Petro, Gregory; Fakier, Ahminah; Langenegger, Eduard; Cluver, Catherine A.; Bekker, Adrie; de Waard, Liesl; Stewart, Chantal; Ngene, Nnabuike C.; Lunda, Ongombe; N.Cebekhulu, Sylvia; Moodley, Siva; Koranteng‐Peprah, Mama‐Asu; Ati, Emmanuel M. C.; Maswime, Salome; Yates, Laura M.
title: Maternal characteristics and pregnancy outcomes of hospitalized pregnant women with SARS‐CoV‐2 infection in South Africa: An International Network of Obstetric Survey Systems‐based cohort study
date: 2021-09-16
journal: Int J Gynaecol Obstet
DOI: 10.1002/ijgo.13917
sha: 40cd88a5f1a895ef5999d759fd59d65348d86612
doc_id: 894717
cord_uid: gsvtl3ef

OBJECTIVE: To describe risk factors and outcomes of pregnant women infected with SARS‐CoV‐2 admitted to South African healthcare facilities. METHODS: A population‐based cohort study was conducted utilizing an amended International Obstetric Surveillance System protocol. Data on pregnant women with SARS‐CoV‐2 infection, hospitalized between April 14, 2020, and November 24, 2020, were analyzed. RESULTS: A total of 36 hospitals submitted data on 673 infected hospitalized pregnant women; 217 (32.2%) were admitted for COVID‐19 illness and 456 for other indications. There were 39 deaths with a case fatality rate of 6.3%: 32 (14.7%) deaths occurred in women admitted for COVID‐19 illness compared to 7 (1.8%) in women admitted for other indications. Of the women, 106 (15.9%) required critical care. Maternal tuberculosis, but not HIV co‐infection or other co‐morbidities, was associated with admission for COVID‐19 illness. Rates of cesarean delivery did not differ significantly between women admitted for COVID‐19 and those admitted for other indications. There were 179 (35.4%) preterm births, 25 (4.7%) stillbirths, 12 (2.3%) neonatal deaths, and 162 (30.8%) neonatal admissions. Neonatal outcomes did not differ significantly from those of infected women admitted for other indications. CONCLUSION: The maternal mortality rate was high among women admitted with SARS‐CoV‐2 infection and higher in women admitted primarily for COVID‐19 illness with tuberculosis being the only co‐morbidity associated with admission.

South Africa reported its first case of SARS-CoV-2 infection in March 2020, the same month that WHO declared SARS-CoV-2 a global pandemic. 1 The first wave of infections peaked in South Africa in July 2020, reaching a nadir by October 2020, with just over 700 000 infections reported. 2 Paralleling the evolution of the pandemic, reports on a multitude of topics related to SARS-CoV-2 infection abounded.

In contrast, pregnancy-related research in the field remains sparse, in particular for low-and middle-income countries (LMICs).

An early report from the United Kingdom Obstetric Surveillance System (UKOSS) highlighted that a high proportion of pregnant women admitted to hospital with SARS-CoV-2 infection were from black or other ethnic minority groups, overweight, had pre-existing medical disorders, or were of advanced maternal age. 3 A systematic review and meta-analysis reported that SARS-CoV-2 infection is associated with an increased risk of admission to the intensive care unit (ICU) for the mother, and preterm birth and admission to the neonatal ICU (NICU) for the infant. 4 Literature available from Africa after the first wave of the pandemic is comparatively sparse, comprising mostly opinion pieces, literature reviews, case studies, and small retrospective analyses with several limitations. [5] [6] [7] [8] Treatment of pregnant women with SARS-CoV-2 has therefore relied on guidance for the general population.

Pregnancy cohort data are required as a matter of priority given the prevalence in Africa of the risk factors for severe illness identified in studies from Western populations.

The primary aim of the present study was to describe the characteristics and outcomes of hospitalized pregnant women infected with SARS-CoV-2 in South Africa who were admitted for treatment of clinical SARS-CoV-2 illness or other indication, in order to inform evidence-based guidance for pregnant women in South Africa.

A multicenter observational cohort study was conducted based on the protocol originally developed by the UKOSS, and subsequently adopted by the International Obstetric Surveillance System (INOSS) to enable a coordinated and standardized international approach to the study of SARS-CoV-2 infection in pregnancy. 3 

A total of 36 hospitals across six provinces in South Africa enrolled in the present study. Completed CRFs were received for 673 women admitted between April 14, 2020, and November 24, 2020, the majority (96%) from state-subsidized hospitals.

The age range of the women was 11-47 years, with 64.6% aged 20-34 years. Using body mass index (BMI, calculated as weight in kilograms divided by the square of height in meters), 55% of women were classified as obese in comparison to using midupper arm circumference (MUAC), which identified the majority (58%) of women to be in the normal range. However, MUAC was only recorded for half of the women. Of the women, 84.6%

were South African. The vast majority of South African women were classified ethnically as black (n = 472, 85.2%), with 9.4% colored, 1.6% Indian, and less than 1% white. Current use of cigarettes and alcohol was reported among 2.7% and 3.6% of women, respectively.

Nearly half the women (n = 322, 47.8%) had at least one preexisting medical condition. HIV infection was the most prevalent (n = 220, 33.4%), followed by hypertension (n = 70, 10.7%). The most recent HIV viral load was available for over 80% of women infected with HIV, identifying 72.5% as virally suppressed. The majority (94.1%) of women infected with HIV were on antiretroviral therapy.

Nearly three-quarters of the women were multiparous. Of them, 24 (3.6%) had multiple pregnancies (Table 1 ).

The majority (n = 539, 83.3%) of women were in the third trimes- were attributed to "other" direct causes (n = 5), hypertensive disease (n = 1), and in four women the cause of death was unknown.

In the remaining 10 cases, a causal association with SARS-CoV-2 infection was uncertain due to the presence of other risk factors and maternal morbidities ( Table 2 ). 

prematurity, birth asphyxia (n = 2), congenital abnormality (n = 2), and other (n = 2) or unknown cause (n = 1) ( Table 3 ).

History of maternal tuberculosis (current or previous) was more frequent among women admitted for treatment of COVID-19 than those admitted for other indications; however, maternal age, BMI, MUAC, and pre-existing morbidities (including HIV infection) did not differ significantly. SARS-CoV-2 symptoms, especially respiratory symptoms, were more commonly reported in the group of women who were admitted for COVID-19. There was no difference for rhinorrhea and diarrhea.

Women admitted for the management of COVID-19 were significantly more likely to need critical care and to die than women infected with SARS-CoV-2 admitted primarily for other medical conditions or for delivery (32.3% vs 8.6%, P < 0.0001 and 14.7% vs 1.8%, P < 0.0001, respectively). Severe acute respiratory failure was the leading primary cause of death in both groups but occurred at a higher frequency among women admitted for clinical SARS-CoV-2 infection (Table 4) .

Women infected with SARS-CoV-2 requiring admission for management of the infection were at a significantly higher risk of ventilation (P < 0.0001), adult respiratory distress syndrome (P < 0.0001), pulmonary edema (P = 0.02), septicemia (P = 0.03), and renal failure (P = 0.04). Gestational age at delivery, mode of delivery, infant birth weight, neonatal mortality, and respiratory distress syndrome rates were, however, comparable across groups. 

The present multicenter, national observational study assessing the symptoms and associations between SARS-CoV-2 infection in pregnancy and maternal and neonatal outcomes in a South African cohort shows that approximately 7.5% of all admitted women required invasive ventilation, three-quarters of whom were admit- More than half (61%) the women admitted for clinical SARS-CoV-2 illness were obese (using BMI) and just over one-third (33%)

were aged 35 years and older. However, late booking is common in South Africa, and MUAC, which may be considered a more reliable marker of nutritional status, 10 Of concern is the high mortality rate in the present cohort, in particular among those admitted primarily due to clinical SARS-CoV-2 illness. Mortality rates in the present cohort are higher than those identified in the UKOSS study, 12 which was based on the same protocol and focused on hospitalized women but predominantly in a high-income setting. The majority of women in the present cohort were from state-subsidized hospitals representing a predominantly low-income population. The INTERCOVID Study showed a risk of maternal mortality of 1.6%, that is, 22 times higher among pregnant women with a diagnosis of COVID-19 than uninfected pregnant women. Deaths were concentrated in institutions from less-developed regions, suggesting greater lethality in lower-income settings. 9 In the present study, mortality was also high for pregnant women admitted for clinical SARS-CoV-2 illness, most of whom were from low-income settings, and also appear to be at higher risk of mortality than women in the UKOSS study.

The present study is strengthened through multi-provincial The present study identifies that mortality is increased among pregnant women admitted for clinical SARS-CoV-2 illness compared to infected women admitted for other indications. There appears to be a greater risk of mortality in pregnant women admitted with SARS-CoV-2 infection in low-income settings with tuberculosis as the only co-morbidity associated with admission. Symptomatic pregnant women should be advised to seek medical attention early, and pregnant women in South Africa must be considered a vulnerable group to be prioritized in vaccination programs for COVID-19.

A research grant was received from the South African Medical

Research Council (SAMRC).

The authors have no conflicts of interest. 

Samantha Budhram https://orcid.org/0000-0002-5747-1714

Rolling Updates on Coronavirus Disease (COVID-19)

Latest confirmed cases of COVID-19 in South Africa

UK Obstetric Surveillance System SARS-CoV-2 Infection in Pregnancy Collaborative Group. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study

Clinical 465 manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 466 2019 in pregnancy: living systematic review and meta-analysis

COVID-19 in the WITS academic circuit

COVID-19 in pregnancy: update on the disease and its management

COVID-19 and the cardiovascular system in pregnancy

Is pregnancy a risk factor of COVID-19?

Maternal and Neonatal Morbidity and Mortality Among Pregnant Women with and without COVID-19 Infection: The INTERCOVID Multinational Cohort Study

Midupper arm circumference in pregnant women and its relation to birth weight

The 2017 National Antenatal Sentinel HIV Survey. National Department of Health

The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from

Maternal and neonatal outcomes of COVID-19 in pregnancy: a single-centre observational study

Maternal characteristics and pregnancy outcomes of hospitalized pregnant women with SARS-CoV-2 infection in South Africa: An International Network of Obstetric Survey Systems-based cohort study